Get more info on this report!

Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends in Egypt, Jordan, Israel, Saudi Arabia and UAE)

November 1, 2008 At present the Middle East region constitutes as small percent of global pharmaceutical sales. However, ever-increasing populations and governmental healthcare reforms are likely to increase demand. These markets will be essential for pharmaceuticals companies exploring new opportunities for growth. Developing regions will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market. This Kalorama Information report, Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends) takes a thorough look at the emerging markets in these countries:

Egypt United Arab Emirates Isreal Saudi Arabia Jordan

As part of its exhuastive coverage, for each country's market, the report includes:

Current Pharmaceutical Market Size Market Forecast Regulatory Environment Economic Statistics Disease and Health Spending Statistics Leading Pharmaceutical Suppliers

In addition, trends that apply to all countries such as generic competition, regulatory matters, Companies profiled in this report include:

Banaja Dar Al Dawa GlaxoSmithKline Egypt Gulf Pharmaceutical Industries Hikma Pharmaceuticals Medical Union Pharmaceutical Company Perrigo Israel Pharco Pharmaceuticals Saudi Pharmaceutical Industries & Medical Appliances Corp. TEVA

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 30 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives. All market data pertains to the world market at the manufacturers level. The base year for data was 2007. Historical data was provided for the years 2005 and 2006, with forecast data provided for 2008 through 2012. Compound annual growth rates (CAGRs) are provided for the 2005-2007 and 2008-2012 periods for each region and/or segment covered. The forecasted market analysis for 2008-2012 was largely based on demographic trends, new developments, and global expansion.

Table of Contents CHAPTER ONE: EXECUTIVE SUMMARY

Overview Scope and Methodology Size and Growth of the Market Key Issues and Trends Affecting the Market Leading Competitors

CHAPTER TWO: INTRODUCTION

Overview Intellectual Property Rights and Compulsory Licensing Biosimilar Production

World Health Tobacco Use Obesity

CHAPTER THREE: PHARMACEUTICAL MARKETS IN ISRAEL

Overview and Summary Regulatory Environment Intellectual Property Rights Economic Development GDP and Healthcare Spending Healthcare Trends in Israel Demographics o Birth Rates o Life Expectancy o Mortality Key Product Segments and Market Indicators o Cardiovascular Disease o Infection Control Disease o Central Nervous System Drugs o Oncology Market Analysis Sales of Pharmaceuticals by Generic Supply Leading Pharmaceutical Suppliers

CHAPTER FOUR: PHARMACEUTICAL MARKETS IN EGYPT

Overview and Summary Regulatory Environment Economic Development GDP and Healthcare Spending Healthcare Trends in Egypt Demographics Birth Rates Life Expectancy Mortality Key Product Segments and Market Indicators Cardiovascular Disease Infection Control Oncology Diabetes Market Analysis Sales of Pharmaceuticals by Generic Supply Leading Pharmaceutical Suppliers

CHAPTER FIVE: PHARMACEUTICAL MARKETS IN SAUDI ARABIA

Overview and Summary Regulatory Environment Intellectual Property Rights Economic Development GDP and Healthcare Spending Healthcare Trends in Saudi Arabia Demographics Birth Rates Life Expectancy Mortality Key Product Segments and Market Indicators Cardiovascular Disease Infection Control Oncology Diabetes and Other Diseases Market Analysis Sales of Pharmaceuticals by Generic Supply Leading Pharmaceutical Suppliers

CHAPTER SIX: PHARMACEUTICAL MARKETS IN JORDAN

Overview and Summary Regulatory Environment Intellectual Property Rights Economic Development GDP and Healthcare Spending Healthcare Trends in Jordan Jordanian Insurance Coverage Demographics Birth Rates Life Expectancy Mortality Key Product Segments and Market Indicators Cardiovascular Disease Infection Control Oncology Diabetes Market Analysis Sales of Pharmaceuticals by Generic Supply Leading Pharmaceutical Suppliers

CHAPTER SEVEN: PHARMACEUTICAL MARKETS IN THE UNITED ARAB EMIRATES

Overview and Summary Regulatory Environment

Intellectual Property Rights Economic Development GDP and Healthcare Spending Healthcare Trends in the UAE Demographics Birth Rates Life Expectancy Mortality Key Product Segments and Market Indicators Cardiovascular Disease Infection Control Oncology Diabetes Market Analysis Sales of Pharmaceuticals by Generic Supply Leading Pharmaceutical Suppliers

CHAPTER SEVEN: MARKET SUMMARY

Overview

CHAPTER EIGHT: LEADING PHARMACEUTICAL PROVIDERS IN THE MIDDLE EAST

Overview Banaja Dar Al Dawa GlaxoSmithKline Egypt Gulf Pharmaceutical Industries (Julphar) Hikma Pharmaceuticals Medical Union Pharmaceutical Company Perrigo Israel Pharco Pharmaceuticals Saudi Pharmaceutical Industries & Medical Appliances Corporation TEVA

APPENDIX: LIST OF MAJOR COMPANIES LIST OF EXHIBITS CHAPTER ONE: EXECUTIVE SUMMARY

Figure 1-1: Middle East Market Analysis: 2005-201

CHAPTER THREE: PHARMACEUTICAL MARKETS IN ISRAEL

Table 3-1: Israels Economic Sectors Table 3-2: Israels GDP and Healthcare Spending Table 3-3: Israel - Midyear Population, by Age and Sex, 2007 and 2012 Figure 3-1: Israel - Midyear Population, by Age, 2007 and 2012 Table 3-4: Israel Fertility Rates and Births, Estimated 2000, 2005; Projected 2010, 2015 Figure 3-2: Israel Fertility Rates and Births, Estimated 2000, 2005; Projected 2010, 2015 Table 3-5: Israel Life Expectancy at Birth, 2000, 2005; Projections, 2010, 2015 and 2020 Figure 3-3: Israel Life Expectancy at Birth by Sex, 2000, 2005; Projections 2010, 2015 and 2020 Table 3-6: Israel Mortality Rates and Numbers, Estimated 2000, 2005; Projected 2010, 2015 Figure 3-4: Israel Mortality Rates and Numbers, Estimated 2000, 2005; Projected 2010, 2015 Table 3-7: Tuberculosis Surveillance and Epidemiology, Israel Table 3-8: Israel Pharmaceutical Market Analysis, 2005-2007 Table 3-9: Israel Pharmaceutical Market Analysis: 2008-2012 Figure 3-5: Israel Pharmaceutical Market Analysis: 2005-2012 Table 3-10: Estimated Sales of Pharmaceuticals in Israel by Generic Or Brand, 2007 Figure 3-6: Estimated Sales of Pharmaceuticals in Israel by Generic Or Brand, 2007

CHAPTER FOUR: PHARMACEUTICAL MARKETS IN EGYPT

Table 4-1: Egypts Economic Sectors Table 4-2: Egypts GDP and Healthcare Spending Table 4-3: Egypt - Midyear Population, by Age and Sex, 2007 and 2012 Figure 4-1: Egypt - Midyear Population, by Age, 2007 and 2012 Table 4-4: Egypt Fertility Rates and Births, Estimated 2000, 2005; Projected 2010, 2015 Figure 4-2: Egypt Fertility Rates and Births, Estimated 2000, 2005; Projected 2010, 2015 Table 4-5: Egypt Life Expectancy at Birth, 2000, 2005; Projections, 2010, 2015 and 2020 Figure 4-3: Egypt Life Expectancy at Birth by Sex, 2000, 2005; Projections 2010, 2015 and 2020 Table 4-6: Egypt Mortality Rates and Numbers - Estimated 2000, 2005; Projected 2010, 2015 Figure 4-4: Egypt Mortality Rates and Numbers: Estimated 2000, 2005; Projected 2010, 2015 Table 4-7: Tuberculosis Surveillance and Epidemiology, Egypt Table 4-8: Egypt Pharmaceutical Market Analysis, 2005-2007 Table 4-9: Egypt Pharmaceutical Market Analysis: 2008-2012

Figure 4-5: Egypt Pharmaceutical Market Analysis: 2005-2012 Table 4-10: Estimated Sales of Pharmaceuticals in Egypt by Generic Or Brand, 2007 Figure 4-6: Estimated Sales of Pharmaceuticals in Egypt by Generic Or Brand, 2007

CHAPTER FIVE: PHARMACEUTICAL MARKETS IN SAUDI ARABIA

Table 5-1: Saudi Arabias Economic Sectors Table 5-2: Saudi Arabias GDP and Healthcare Spending Table 5-3: Saudi Arabia - Midyear Population, by Age and Sex, 2007 and 2012 Figure 5-1: Saudi Arabia - Midyear Population, by Age, 2007 and 2012 Table 5-4, Saudi Arabia Fertility Rates and Births - Estimated 2000, 2005; Projected 2010, 2015 Figure 5-2: Saudi Arabia Fertility Rates and Births - Estimated 2000, 2005; Projected 2010, 2015 Table 5-5: Saudi Arabia Life Expectancy at Birth, 2000, 2005; Projections, 2010, 2015 and 2020 Figure 5-3: Saudi Arabia Life Expectancy at Birth by Sex, 2000, 2005; Projections 2010, 2015 and 2020 Table 5-6: Saudi Arabia Mortality Rates and Numbers, Estimated 2000, 2005; Projected 2010, 2015 Figure 5-4: Saudi Arabia Mortality Rates and Numbers - Estimated 2000, 2005; Projected 2010, 2015 Table 5-7: Tuberculosis Surveillance and Epidemiology, Saudi Arabia Table 5-8: Saudi Arabia Cancer Incidence in Men and Women 2006 Table 5-9: Saudi Arabia Pharmaceutical Market Analysis, 2005-2007 Table 5-10: Saudi Arabia Pharmaceutical Market Analysis: 2008-2012 Figure 5-4: Saudi Arabia Pharmaceutical Market Analysis: 2005-2012 Table 5-11: Estimated Sales of Pharmaceuticals in Saudi Arabia by Generic Or Brand, 2007 Figure 5-5: Estimated Sales of Pharmaceuticals in Saudi Arabia by Generic Or Brand, 2007

CHAPTER SIX: PHARMACEUTICAL MARKETS IN JORDAN

Table 6-1: Jordans Economic Sectors Table 6-2: Jordans GDP and Healthcare Spending Table 6-3: Jordan - Midyear Population, by Age and Sex, 2007 and 2012 Figure 6-1: Jordan - Midyear Population, by Age, 2007 and 2012 Table 6-4: Jordan Fertility Rates and Births - Estimated 2000, 2005; Projected 2010, 2015 Figure 6-2: Jordan Fertility Rates and Births - Estimated 2000, 2005; Projected 2010, 2015 Table 6-5: Jordan Life Expectancy at Birth, 2000, 2005; Projections, 2010, 2015 and 2020

Figure 6-3L Jordan Life Expectancy at Birth by Sex, 2000, 2005; Projections 2010, 2015 and 2020 Table 6-6: Jordan Mortality Rates and Numbers - Estimated 2000, 2005; Projected 2010, 2015 Figure 6-4: Jordan Mortality Rates and Numbers - Estimated 2000, 2005; Projected 2010, 2015 Table 6-7: Tuberculosis Surveillance and Epidemiology, Jordan Table 6-8: Jordan Pharmaceutical Market Analysis, 2005-2007 Table 6-9: Jordan Pharmaceutical Market Analysis: 2008-2012 Figure 6-5: Jordan Pharmaceutical Market Analysis: 2005-2012 Table 6-10: Estimated Sales of Pharmaceuticals in Jordan by Generic Or Brand, 2007 Figure 6-6: Estimated Sales of Pharmaceuticals in Jordan by Generic Or Brand, 2007

CHAPTER SEVEN: PHARMACEUTICAL MARKETS IN THE UNITED ARAB EMIRATES

Table 7-1: United Arab Emirates Economic Sectors Table 7-2: United Arab Emirates GDP and Healthcare Spending Table 7-3: UAE - Midyear Population, by Age and Sex, 2007 and 2012 Figure 7-1: UAE - Midyear Population, by Age, 2007 and 2012 Table 7-4: UAE Fertility Rates and Births - Estimated 2000, 2005; Projected 2010, 2015 Figure 7-2: UAE Fertility Rates and Births - Estimated 2000, 2005; Projected 2010, 2015 Table 7-5: UAE Life Expectancy at Birth, 2000, 2005; Projections, 2010, 2015 and 2020 Figure 7-3: UAE Life Expectancy at Birth by Sex, 2000, 2005; Projections 2010, 2015 and 2020 Table 7-6: UAE Mortality Rates and Numbers - Estimated 2000, 2005; Projected 2010, 2015 Figure 7-4: UAE Mortality Rates and Numbers - Estimated 2000, 2005; Projected 2010, 2015 Table 7-7: UAE Pharmaceutical Market Analysis, 2005-2007 Table 7-8: UAE Pharmaceutical Market Analysis: 2008-2012 Figure 7-5: UAE Pharmaceutical Market Analysis: 2005-2012 Table 7-9: Estimated Sales of Pharmaceuticals in UAE by Generic Supply, 2007 Figure 7-6: Estimated Sales of Pharmaceuticals in UAE by Generic Or Brand, 2007

CHAPTER EIGHT: MARKET SUMMARY

Table 8-1: Pharmaceutical Markets in the Middle East: Market Analysis, 20052007

Table 8-2: Pharmaceutical Markets in the Middle East: Market Analysis: 20082012 Figure 8-1: Pharmaceutical Markets in the Middle East: Market Analysis: 20052012 Table 8-3: Middle East Pharmaceutical Markets by Country, 2007 Figure 8-2: Middle East Pharmaceutical Markets by Country, 2007

Available immediately for Online Download at

http://www.marketresearch.com/product/display.asp?productid=1646593

US: 800.298.5699 UK +44.207.256.3920 Int'l: +1.240.747.3093 Fax: 240.747.3004